What is the recommended treatment for uncomplicated genital Chlamydia trachomatis infection, including options for pregnant patients and those with a penicillin allergy?

Treatment for Chlamydia

For uncomplicated genital chlamydia in non-pregnant adults, treat with either azithromycin 1 g orally as a single dose OR doxycycline 100 mg orally twice daily for 7 days—both are equally effective. 1, 2

Standard Treatment Regimens

First-Line Options (Non-Pregnant Adults)

The CDC guidelines establish two equally efficacious recommended regimens:

• Azithromycin 1 g orally in a single dose, OR
• Doxycycline 100 mg orally twice daily for 7 days 1, 2

Clinical trials demonstrate equal efficacy between these agents 1. The choice depends on practical considerations:

• Choose azithromycin when: Compliance is questionable, patient has erratic healthcare-seeking behavior, or directly observed therapy is needed 1
• Choose doxycycline when: Cost is a concern (significantly less expensive) or you have a compliant patient 1

Alternative Regimens (If First-Line Not Tolerated)

• Erythromycin base 500 mg orally four times daily for 7 days, OR
• Erythromycin ethylsuccinate 800 mg orally four times daily for 7 days, OR
• Ofloxacin 300 mg orally twice daily for 7 days, OR
• Levofloxacin 500 mg orally daily for 7 days 1, 2

Important caveat: Erythromycin is less efficacious than azithromycin or doxycycline, and gastrointestinal side effects frequently reduce compliance 1. Ofloxacin offers similar efficacy but is more expensive with no dosing advantage 1.

Treatment in Pregnancy

Doxycycline and all fluoroquinolones (ofloxacin, levofloxacin) are absolutely contraindicated in pregnancy 1.

Recommended Regimens for Pregnant Women

• Erythromycin base 500 mg orally four times daily for 7 days, OR
• Amoxicillin 500 mg orally three times daily for 7 days 1

Alternative Regimens for Pregnant Women

• Erythromycin base 250 mg orally four times daily for 14 days, OR
• Erythromycin ethylsuccinate 800 mg orally four times daily for 7 days, OR
• Erythromycin ethylsuccinate 400 mg orally four times daily for 14 days, OR
• Azithromycin 1 g orally in a single dose 1

Critical note: Erythromycin estolate is contraindicated in pregnancy due to drug-related hepatotoxicity 1. While preliminary data suggest azithromycin may be safe and effective in pregnancy, the 1998 guidelines noted insufficient data for routine use 1. However, a 2017 Cochrane review found that amoxicillin and erythromycin showed no difference in efficacy, and azithromycin resulted in fewer side effects than erythromycin 3.

Repeat testing is essential in pregnancy: Perform test of cure, preferably by culture, 3 weeks after completion of therapy because none of these pregnancy regimens are highly efficacious and erythromycin side effects may reduce compliance 1.

Penicillin Allergy Considerations

Penicillin allergy is not a barrier to standard chlamydia treatment because the first-line agents (azithromycin and doxycycline) are not penicillins. For pregnant patients with penicillin allergy who cannot take amoxicillin, use erythromycin-based regimens or azithromycin as outlined above 1.

Special Populations

HIV-Infected Patients

Treat with the same regimens as HIV-negative patients—no modification needed 1.

Patients with Gonococcal Co-infection

Presumptive treatment for chlamydia is appropriate for all patients being treated for gonorrhea, as co-infection is common 1.

Critical Management Points

Sexual Abstinence

• Patients must abstain from sexual intercourse for 7 days after single-dose therapy (azithromycin) or until completion of 7-day regimens 1
• Abstinence must continue until all sex partners complete treatment to prevent reinfection 1

Partner Management

• Evaluate and treat all sex partners who had contact within 60 days preceding symptom onset or diagnosis 1
• Treat the most recent partner even if contact was >60 days before diagnosis 1

Follow-Up Testing

• No test of cure needed after doxycycline or azithromycin unless symptoms persist or reinfection is suspected—these therapies are highly efficacious 1
• If testing is performed, wait at least 3 weeks after treatment completion to avoid false-positive results from dead organisms 1
• Consider rescreening several months later in high-risk populations (e.g., adolescents) due to high reinfection rates 1

Medication Dispensing

Dispense medications on-site and directly observe the first dose to maximize compliance 1. This is particularly important for azithromycin's single-dose regimen.

Common Pitfalls to Avoid

1. Don't use quinolones in pregnancy or adolescents ≤17 years 4
2. Don't test for cure <3 weeks post-treatment—may yield false-positive results 1
3. Don't use erythromycin estolate in pregnancy—causes hepatotoxicity 1
4. Don't assume compliance with 7-day regimens in populations with poor follow-up—use azithromycin 1
5. Don't forget to treat partners—failure to do so leads to reinfection 1